# bioMérieux S.A. (BIM.PA): MoatMap facts

As of 21 Nov 2026. Research data, not investment advice.

As of 21 Nov 2026, the MoatMap Score for bioMérieux S.A. (BIM.PA) is 92/100, ranked against 25,000+ stocks in 38 markets (Quality 74, Value 53, Momentum 71, each scored against its sector).

- MoatMap Score: 92/100, a percentile across 25,000+ stocks in 38 markets (100 is best).
- Quality 74, Value 53, Momentum 71: each a 0-100 percentile within Healthcare.
- Position: #2,134 overall, #244 in Healthcare.
- Listing: France, PAR; Healthcare / Diagnostics & Research.
- Last close: 91.3 EUR on 20 Nov 2026.
- Insider filings, last 180 days: directors sold USD 736K.

Source: https://moatmap.ai/stock/BIM.PA
How the scores work: https://moatmap.ai/methodology
Does the score work? Each tenth of the ranking is tracked monthly: https://moatmap.ai/decile-tracker
